Hi All
I jumped onboard today with a small position. Seems like an interesting few months ahead.
Just one open question... If the path forward for Galidisivir is as straightforward as some are suggesting, why didn't BioCryst Pharmaceuticals do their own animal study and then take the drug to final approval themselves? They certainly seem to have the resources to do so.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $31.87M | |||
| Open | High | Low | Value | Volume |
| 13.5¢ | 14.0¢ | 13.3¢ | $36.85K | 269.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 6030 | 13.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.0¢ | 154000 | 3 |
View Market Depth
| Last trade - 15.33pm 25/06/2025 (20 minute delay) ? |
| ILA (ASX) Chart |